Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 known ✓ | P35354 | 7/20 | 0.46 |
| ▸ | ALOX5 known ✓ | P09917 | 4/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.39 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29700748 | 1.00 | GPR84 (0.69) | GPR84PTGS2CYP3A4ALDH1A1ALOX5 | |
| SCHEMBL17678365 | 0.85 | GPR84 (0.53) | GPR84PTGS2CYP3A4ALDH1A1ALOX5 | |
| SCHEMBL29555599 | 0.84 | ALDH1A1 (0.56) | GPR84PTGS2CYP3A4ALDH1A1ALOX5 | |
| SCHEMBL16050413 | 0.84 | ALDH1A1 (0.56) | GPR84PTGS2CYP3A4ALDH1A1ALOX5 | |
| SCHEMBL19166809 | 0.84 | GPR84 (0.51) | GPR84PTGS2CYP3A4ALDH1A1ALOX5 | |
| SCHEMBL17678366 | 0.84 | GPR84 (0.51) | GPR84PTGS2CYP3A4ALDH1A1ALOX5 | |
| SCHEMBL17672982 | 0.84 | GPR84 (0.67) | GPR84PTGS2CYP3A4ALDH1A1ALOX5 | |
| SCHEMBL1160403 | 0.83 | PTGS2 (0.63) | GPR84PTGS2CYP3A4ALDH1A1ALOX5 | |
| SCHEMBL25346230 | 0.83 | GPR84 (0.50) | GPR84PTGS2CYP3A4ALDH1A1ALOX5 | |
| SCHEMBL19166230 | 0.83 | PTGS2 (0.50) | GPR84PTGS2CYP3A4ALDH1A1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240043372-A1 | SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | PHARMACEUTIQUE INGENEW INC. (CA) | 2024-02-08 | — | — | US | disclosed |
| EP-4225724-A1 | SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | Pharmaceutique Ingenew Inc. (CA) | 2023-08-16 | — | — | EP | disclosed |
| CN-116568291-A | Substituted aromatic compounds and pharmaceutical compositions thereof | 殷格纽制药有限公司 | 2023-08-08 | — | — | CN | disclosed |
| US-11524930-B2 | Substituted aromatic compounds and related method for the treatment of fibrosis | Liminal Biosciences Limited (GB) | 2022-12-13 | — | — | US | disclosed |
| WO-2022073115-A1 | SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | BIOPHARMACEUTIQUES INGENEW INC. (CA) | 2022-04-14 | — | — | WO | disclosed |
| CN-110105200-B | Substituted aromatic compounds for treating fibrosis and related methods | 里米诺生物科学有限公司 | 2022-04-12 | — | — | CN | disclosed |
| US-11185521-B2 | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis | Liminal Biosciences Limited (GB) | 2021-11-30 | — | — | US | disclosed |
| CN-107106526-B | Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration | 普罗米蒂克医药SMT有限公司 | 2021-05-28 | — | — | CN | disclosed |
| CN-106999458-B | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes | 普罗米蒂克医药SMT有限公司 | 2021-04-13 | — | — | CN | disclosed |
| US-20210085626-A1 | SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TISSUE SELF-REPAIR AND REGENERATION | LIMINAL BIOSCIENCES LTD (GB) | 2021-03-25 | — | — | US | disclosed |
| CN-106999456-A | substituted aromatic compounds and pharmaceutical composition for preventing and treating osteoporosis | 普罗米蒂克医药SMT有限公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-106999458-A | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes | 普罗米蒂克医药SMT有限公司 | 2017-08-01 | — | — | CN | disclosed |
| US-20170209399-A1 | Substituted Aromatic Compounds and Pharmaceutical Compositions For The Prevention And Treatment Of Diabetes | PROMETIC PHARMA SMT LIMITED (GB) | 2017-07-27 | — | — | US | disclosed |
| WO-2016074068-A1 | SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TISSUE SELF-REPAIR AND REGENERATION | PROMETIC BIOSCIENCES INC. (CA) | 2016-05-19 | — | — | WO | disclosed |
| WO-2016054728-A1 | SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS | PROMETIC BIOSCIENCES INC. (CA) | 2016-04-14 | — | — | WO | disclosed |
| WO-2016054726-A1 | SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DIABETES | PROMETIC BIOSCIENCES INC. (CA) | 2016-04-14 | — | — | WO | disclosed |
| US-20160039736-A1 | Substituted Aromatic Compounds and Related Method for the Treatment of Fibrosis | Liminal Biosciences Limited (GB) | 2016-02-11 | — | — | US | disclosed |
| EP-2970089-A1 | SUBSTITUTED AROMATIC COMPOUNDS AND RELATED METHOD FOR THE TREATMENT OF FIBROSIS | ProMetic BioSciences Inc. (CA) | 2016-01-20 | — | — | EP | disclosed |
| CN-105189438-A | Substituted aromatic compounds for treating fibrosis and related methods | PROMETIC BIOSCIENCES INC | 2015-12-23 | — | — | CN | disclosed |
| WO-2014138906-A1 | SUBSTITUTED AROMATIC COMPOUNDS AND RELATED METHOD FOR THE TREATMENT OF FIBROSIS | PROMETIC BIOSCIENCES INC. (CA) | 2014-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210085626-A1 | SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TISSUE SELF-REPAIR AND REGENERATION | COL1A1, CCNH, COL2A1 | PTGS2 322/4885ALOX5 1125/4885GPR84 1983/4885 |
| US-11524930-B2 | Substituted aromatic compounds and related method for the treatment of fibrosis | CFH, C5, C9 | PTGS2 2040/4885ALOX5 496/4885GPR84 1802/4885 |
| US-20240043372-A1 | SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | NR1H4, NR1H2, NR1H3 | PTGS2 1129/4885ALOX5 1470/4885GPR84 421/4885 |
| US-20160039736-A1 | Substituted Aromatic Compounds and Related Method for the Treatment of Fibrosis | CFH, C9, C5 | PTGS2 2200/4885ALOX5 983/4885GPR84 2045/4885 |
| US-20170209399-A1 | Substituted Aromatic Compounds and Pharmaceutical Compositions For The Prevention And Treatment Of Diabetes | GPR119, LIPC, INSR | PTGS2 2425/4885ALOX5 1146/4885GPR84 1382/4885 |
| US-11185521-B2 | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis | ADIPOR1, ADIPOR2, FN1 | PTGS2 2609/4885ALOX5 565/4885GPR84 632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.